Surgery without stitches

Dec 21, 2007

A thin polymer bio-film that seals surgical wounds could make sutures a relic of medical history. Measuring just 50 microns thick, the film is placed on a surgical wound and exposed to an infrared laser, which heats the film just enough to meld it and the tissue, thus perfectly sealing the wound.

Known as Surgilux, the device’s raw material is extracted from crab shells and has Food and Drug Administration approval in the US.

Early test results indicate that it has strongest potential for use in brain and nerve surgery because it can avoid the numerous disadvantages of invasive stictches/sutures, which fail to seal and can act as a source of infection.

Up to 11% of brain surgery patients have to return for repeat surgery due to leakage of cerebro-spinal fluid (CSF) and other complications arising from sutures.

Surgical sutures date back some 4,000 years, so a new approach is long overdue, according to one of the device’s inventors and leader of the Bio/polymer Research Group, UNSW scientist John Foster.

“Others have tried surgical glues but these are mainly gel-like so bonding to the tissue is uneven often resulting in leakages and they’re not easy to use. The strongest surgical glue is so toxic that it’s limited to external applications,” says Dr Foster. “Other devices use ultra-violet light to effect rather poor sealing, but UV rays are damaging to living cells

“The beauty of this is that infra-red laser doesn’t cause any tissue damage. Better still, Surgilux has anti-microbial properties, which deters post-operative infections.”

Foster and his team are working with micro-surgeon Marcus Stoodley who specialises in nerve repair. Based at the Prince of Wales Hospital Stoodley is excited about early test results.

“Surgilux is well suited to repairing damaged nerves because the gold standard -- sutures – inevitably cause damage to nerves and there is always some permanent loss of function.

“Our test results with rats have shown some degree of permanent nerve recovery within six weeks of operating.”

The researchers – who are looking for commercial backing to initiate clinical trials – are planning a second generation version of Surgilux that incorporates growth factors and perhaps stem cells to regenerate nerves.

Source: University of New South Wales

Explore further: AbbVie to pay Shire $1.64B fee over nixed merger

add to favorites email to friend print save as pdf

Related Stories

Partial solar eclipse over the U.S. on Thursday, Oct. 23

50 minutes ago

People in most of the continental United States will be in the shadow of the Moon on Thursday afternoon, Oct. 23, as a partial solar eclipse sweeps across the Earth. For people looking through sun-safe filters, from Los Angeles, ...

UN biodiversity meet commits to double funding

9 minutes ago

A UN conference on preserving the earth's dwindling resources wrapped up Friday with governments making a firm commitment to double biodiversity aid to developing countries by 2015.

Apple starts iPhone 6 sales in key China market

54 minutes ago

Apple began selling its latest iPhone in China Friday, nearly a month after other major territories due to a licence delay by regulators, but it faces a tough battle with rivals led by Samsung in the crucial ...

Recommended for you

New MCAT shifts focus, will include humanities

8 hours ago

(HealthDay)—The Medical College Admission Test (MCAT) has been revised, and the latest changes, including more humanities such as social sciences, are due to be implemented next April, according to a report ...

Using feminist theory to understand male rape

19 hours ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

NeilFarbstein
not rated yet Dec 21, 2007
Vulvox Nanobiotechnology Corporation has developed a breakthrough carbon nanotube adhesive that sticks to soft rubber and other materials with similar consistency especially human flesh and skin. It will be used to close woulds, reversibly and it clings to wet buccal tissue in the mouth and the tongue as well as wet flesh that is too wet with bodily fluids to apply adhesive bandages. You can view pictures of the nanotube adhesive at;

http://vulvox.tripod.com

navigate to the Nanotube adhesive press release link.